Mailing List Sign-Up

Device Post-Marketing & Reimbursement Conference


At the recent Medical Device Post-Marketing Research & Reimbursement Conference that took place May 14-15 in SanMateo, California, attendees were thrilled with the opportunity to network and share best practices from within the industry. Feedback focused around a quality conference agenda highlighting the variety of speakers, backgrounds and topics.

Sessions and Feedback Included:

Creating a Unified Approach to Device Post-Marketing Trials

Peter Edelstein
President & CEO
Aragon Surgical Inc.

*As the keynote speaker, Dr. Edelstein set the stage for this event with his impressive presentation on creating a unified approach to clinical trials. Feedback generated from this presentation was overwhelming with praise. Many commented that in addition to being entertaining, his session provided them with excellent and useful information that can be taken back and implemented in their own organizations.

Utilizing a Post-Market Research Study to Increase Product Commercialization
Charles Schnieder
Vice President, Reimbursement
Musculoskeletal Clinical Regulatory Advisors

*Charles Schneider's session addressed the challenges of medical device reimbursement and commercialization strategies. Attendees commented that his knowledgeable and detailed presentation provided them with excellent materials for future reference related to strategic reimbursement planning processes.

Workshop: Applying ?Systems Thinking? to your Post-Market Surveillance Study
Jill Visor
Director, West Coast Operations
Alquest
Julie Hoff
Senior Principal Consultant
Alquest

*Jill Visor and Julie Hoff bestowed attendees with a constructive workshop dedicated to Applying "Systems Thinking" to Post Market Surveillance. Attendee feedback recalled the presentation has an excellent highly interactive experience.

Weighing the Financial and Operational Benefits of Patient Registries vs. Post-Marketing Clinical Trials
Charles Carignan
CMO and VP, Clinical
Novasys Medical

*Charles addressed the issue of the financial and operational benefits of patient registries and post-marketing clinical Trials. Charles use of valuable content created an exceptional presentation that was well-received by the audience.